Ling X, Wan J, Peng B, Chen J
J Oncol. 2021; 2021:7873085.
PMID: 34868316
PMC: 8642011.
DOI: 10.1155/2021/7873085.
Meyer K, Shapiro T
Antimicrob Agents Chemother. 2021; 65(11):e0063221.
PMID: 34424040
PMC: 8522745.
DOI: 10.1128/AAC.00632-21.
Yu L, Lang Y, Guo J, Cai J, Shang Z, Chen B
Cell Cycle. 2021; 20(2):211-224.
PMID: 33404279
PMC: 7889180.
DOI: 10.1080/15384101.2020.1867790.
Cunningham C, MacAuley M, Vizeacoumar F, Abuhussein O, Freywald A, Vizeacoumar F
Cancers (Basel). 2020; 12(10).
PMID: 33066048
PMC: 7599805.
DOI: 10.3390/cancers12102953.
Moison C, Lavallee V, Thiollier C, Lehnertz B, Boivin I, Mayotte N
Blood Adv. 2019; 3(4):552-563.
PMID: 30782614
PMC: 6391664.
DOI: 10.1182/bloodadvances.2018028480.
Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer.
Chen L, Li J, Farah E, Sarkar S, Ahmad N, Gupta S
Mol Cancer Ther. 2016; 15(9):2107-18.
PMID: 27390342
PMC: 5010925.
DOI: 10.1158/1535-7163.MCT-16-0241.
Differences in the ovine HSP90AA1 gene expression rates caused by two linked polymorphisms at its promoter affect rams sperm DNA fragmentation under environmental heat stress conditions.
Salces-Ortiz J, Ramon M, Gonzalez C, Perez-Guzman M, Garde J, Garcia-Alvarez O
PLoS One. 2015; 10(2):e0116360.
PMID: 25671615
PMC: 4324765.
DOI: 10.1371/journal.pone.0116360.
Understanding the Polo Kinase machine.
Archambault V, Lepine G, Kachaner D
Oncogene. 2015; 34(37):4799-807.
PMID: 25619835
DOI: 10.1038/onc.2014.451.
HSP90 inhibition enhances antimitotic drug-induced mitotic arrest and cell death in preclinical models of non-small cell lung cancer.
OConnell B, OCallaghan K, Tillotson B, Douglas M, Hafeez N, West K
PLoS One. 2014; 9(12):e115228.
PMID: 25542032
PMC: 4277299.
DOI: 10.1371/journal.pone.0115228.
Regulation of Greatwall kinase by protein stabilization and nuclear localization.
Yamamoto T, Wang L, Fisher L, Eckerdt F, Peng A
Cell Cycle. 2014; 13(22):3565-75.
PMID: 25483093
PMC: 4612739.
DOI: 10.4161/15384101.2014.962942.
Centrosomes at M phase act as a scaffold for the accumulation of intracellular ubiquitinated proteins.
Kimura H, Miki Y, Nakanishi A
Cell Cycle. 2014; 13(12):1928-37.
PMID: 24743317
PMC: 4111756.
DOI: 10.4161/cc.28896.
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression.
He S, Zhang C, Shafi A, Sequeira M, Acquaviva J, Friedland J
Int J Oncol. 2012; 42(1):35-43.
PMID: 23152004
PMC: 3583620.
DOI: 10.3892/ijo.2012.1698.
Hsp90 interaction with Cdc2 and Plo1 kinases contributes to actomyosin ring condensation in fission yeast.
Santino A, Tallada V, Jimenez J, Garzon A
Curr Genet. 2012; 58(4):191-203.
PMID: 22543982
DOI: 10.1007/s00294-012-0376-4.
Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models.
Proia D, Sang J, He S, Smith D, Sequeira M, Zhang C
Invest New Drugs. 2012; 30(6):2201-9.
PMID: 22227828
PMC: 3484281.
DOI: 10.1007/s10637-011-9790-6.
Cdc28 provides a molecular link between Hsp90, morphogenesis, and cell cycle progression in Candida albicans.
Senn H, Shapiro R, Cowen L
Mol Biol Cell. 2011; 23(2):268-83.
PMID: 22090345
PMC: 3258172.
DOI: 10.1091/mbc.E11-08-0729.
High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888.
Lyman S, Crawley S, Gong R, Adamkewicz J, McGrath G, Chew J
PLoS One. 2011; 6(3):e17692.
PMID: 21408192
PMC: 3049797.
DOI: 10.1371/journal.pone.0017692.
Induction of premature senescence by hsp90 inhibition in small cell lung cancer.
Restall I, Lorimer I
PLoS One. 2010; 5(6):e11076.
PMID: 20552022
PMC: 2884022.
DOI: 10.1371/journal.pone.0011076.
Natural product Celastrol destabilizes tubulin heterodimer and facilitates mitotic cell death triggered by microtubule-targeting anti-cancer drugs.
Jo H, Loison F, Hattori H, Silberstein L, Yu H, Luo H
PLoS One. 2010; 5(4):e10318.
PMID: 20428237
PMC: 2859055.
DOI: 10.1371/journal.pone.0010318.
The Hsp90 inhibitor geldanamycin abrogates colocalization of eIF4E and eIF4E-transporter into stress granules and association of eIF4E with eIF4G.
Suzuki Y, Minami M, Suzuki M, Abe K, Zenno S, Tsujimoto M
J Biol Chem. 2009; 284(51):35597-604.
PMID: 19850929
PMC: 2790990.
DOI: 10.1074/jbc.M109.036285.
Absence of tumor-specific over-expression of Polo-like kinase 1 (Plk1) in major non-Hodgkin lymphoma and relatively low expression of Plk1 in nasal NK/T cell lymphoma.
Imai H, Sugimoto K, Isobe Y, Sasaki M, Yasuda H, Takeuchi K
Int J Hematol. 2009; 89(5):673-8.
PMID: 19452252
DOI: 10.1007/s12185-009-0325-2.